story of the week
Frexalimab: A Novel Molecule to Treat MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Inhibition of CD40L with Frexalimab in Multiple Sclerosis
N. Engl. J. Med 2024 Feb 15;390(7)589-600, P Vermersch, C Granziera, Y Mao-Draayer, G Cutter, O Kalbus, I Staikov, M Dufek, S Saubadu, R Bejuit, P Truffinet, B Djukic, E Wallstroem, G GiovannoniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.